Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
V212 Lot-to-Lot Consistency in Healthy Adults
NCT02180295Phase 3Withdrawn
- Sponsor
- Merck & Co.
- Start
- Jul 2014
- Primary completion
- Mar 2015
01
Overview
Phase 3, randomised, double-blind trial of zoster vaccine live in herpes zoster (HZ) (3 arms), sponsored by Merck & Co. Primary endpoint: VZV Glycoprotein Enzyme-Linked Immunosorbent Assay Antibody Titers. Planned start Jul 2014; status: withdrawn.
02
Drugs
zoster vaccine live
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT02180295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02180295.